21 May 2009
Analysis of electrophysiological parameters acquired using continuous holter ecg monitoring in renal transplant patients
J Biernawska, M Zukowski, K Kotfis, M Kaczmarczyk, W Blaszczyk, M Zegan, R Bohatyrewicz, M BrykczynskiAnn Transplant 2009; 14(1): 56-56 :: ID: 880402
Abstract
Background: Metabolic disturbances during renal transplant can lead to electrophysiological and hemodynamic complications. Aims: To determine a relationship between electrophysiological parameters, metabolic homeostasis, length of cold ischemia time (CIT) and warm ischemia time (WIT).
Material/Methods: 54 renal transplant patients were included in a prospective study (mean age 45±12). Prior to procedure arterial blood gases' analysis was performed, digital holter ECG monitoring applied and continued for 12 hours. Second arterial blood gases' analysis was performed 30 minutes after graft's reperfusion. Electrophysiological parameters (rhythm disturbances, variation in the QT period, sinus rhythm variability) and metabolic parameters were analysed depending on the length of CIT and WIT.
Results: Mean CIT was 20 hours, WIT 22 minutes. Mean QTc period was initially 467ms, with its post-reperfusion lengthening to maximal values and gradual decrease during the first hour to initial values. Rapid QTc normalization was observed in WIT group (<17 minutes), dynamics of change were independent of CIT's length. Serious ventricular arrhythmia was observed in one patient. No significant changes were noticed when comparing metabolic compensation in the groups with CIT above and below 20 hours and groups with WIT below and above 22 minutes. Sinus rhythm variability was significantly disturbed in the group with WIT >16 minutes and was independent of the length of CIT.
Conclusions: 1. Prolongation of WIT results in repolarisation disturbances and presence of "fixed sinus rhythm". 2. Prolongation of CIT has no effect on lengthening of QTc or heart rate variability.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






